Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 5, 2019, before the open
10-K filed Mar 7, 2019, 66 days after period end · 0001564590-19-006602
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.14K | — | — | — |
| Net Income | -$8.52M | -$6.24M | -$3.52M | -$11.83K |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| EPS Diluted | -$0.21 | -$0.23 | -$4.76 | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.